Multi-kinase inhibitor 4
Compound 14 is a potent, orally bioavailable multi-kinase inhibitor targeting VEGFRs (FLT1/KDR/FLT4), FLT3, and PDGFRs with low nanomolar IC50 values. It is a valuable research tool for investigating angiogenesis and oncogenesis in both cellular assays and in vivo cancer models.
Product Specifications
CAS Number
2648279-77-8
Field of Research
Cardiovascular Research, Pharmacology & Drug Discovery, Signal Transduction
Smiles
O=C (NC=1ON=C (C1) C (C) (C) C) CC2=CC=C (C=C2) N3C=NC=4C=C (C=CC43) C=5C=NNC5
Molecular Formula
C25H24N6O2
Molecular Weight
440.50
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC680721-100 1x 100 µL
VEGFR2 / Flk-1 / KDR3 / CD309 (KDR721), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 